Follow the 쓰리빌리언 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 쓰리빌리언 has logged 1 insider filings. Market capitalisation: €153.4bn. The latest transaction was disclosed on 1 April 2026 (Purchase). Among the most active insiders: 국민연금공단. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
쓰리빌리언 是一家在 XKRX 市场上市的医疗保健和制药领域的公司。它专注于开发创新解决方案以改善患者健康。